For both 2- and 10-week mortality outcomes, there was a nonsignificant trend toward reduced mortality with escalating dosage ( Fig. 5 ).
← all excerpts
Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis.
1
—
—